Optimization of rhodanine scaffold for the development of protein-protein interaction inhibitors

被引：5

作者：

Ferro, Stefania ^{[1
]}

De Luca, Laura ^{[1
]}

Agharbaoui, Fatima Ezzahra ^{[1
]}

Christ, Frauke ^{[2
,3
]}

Debyser, Zeger ^{[2
,3
]}

Gitto, Rosaria ^{[1
]}

机构：

[1] Univ Messina, Dipartimento Sci Farmaco & Prod Salute, I-98168 Messina, Italy

[2] Katholieke Univ Leuven, Mol Med, B-3000 Leuven, Flanders, Belgium

[3] IRC KULAK, B-3000 Leuven, Flanders, Belgium

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2015年 / 23卷 / 13期

关键词：

Docking studies; Synthesis; Protein-protein interactions; Antiviral activity; HIV-1; INTEGRASE; MOLECULAR-MECHANICS; BINDING-SITE; LEDGF/P75; INSIGHT; DISCOVERY; ADHERENCE; DOCKING; DESIGN;

D O I：

10.1016/j.bmc.2015.04.072

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Searching for novel protein-protein interactions inhibitors (PPIs) herein we describe the identification of a new series of rhodanine derivatives. The selection was performed by means virtual-screening, docking studies, Molecular Dynamic (MD) simulations and synthetic approaches. All the new obtained compounds were tested in order to evaluate their ability to inhibit the interaction between the HIV-1 integrase (IN) enzyme and the nuclear protein lens epithelium growth factor LEDGF/p75. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：3208 / 3214

页数：7

共 50 条

[21] Pharmacophore Modelling as a Virtual Screening Tool for the Discovery of Small Molecule Protein-protein Interaction Inhibitors
Voet, Arnout
Zhang, Kam Y. J.
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4586 - 4598
[22] Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors
Sable, Rushikesh
Jois, Seetharama
MOLECULES, 2015, 20 (06): : 11569 - 11603
[23] Impact of Hydrogen-Bond Surrogate Model on Helix Stabilization and Development of Protein-Protein Interaction Inhibitors
Pal, Sunit
CHEMISTRYSELECT, 2023, 8 (10):
[24] Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction
Wells, Geoff
BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 674 - 679
[25] Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Premnath, Padmavathy Nandha
Craig, Sandra
McInnes, Campbell
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (104):
[26] Exploring the chemical space of protein-protein interaction inhibitors through machine learning
Choi, Jiwon
Yun, Jun Seop
Song, Hyeeun
Kim, Nam Hee
Kim, Hyun Sil
Yook, Jong In
SCIENTIFIC REPORTS, 2021, 11 (01)
[27] Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction
Beloglazkina, Anastasia
Zyk, Nikolai
Majouga, Alexander
Beloglazkina, Elena
MOLECULES, 2020, 25 (05):
[28] A Modular Scaffold for Controlling Transcriptional Activation via Homomeric Protein-Protein Interactions
Lee, ByungUk
Wang, Tina
ACS SYNTHETIC BIOLOGY, 2022, 11 (10): : 3198 - 3206
[29] Development of structure-based pharmacophore to target the β-catenin-TCF protein-protein interaction
Pagare, Piyusha P.
Morris, Andrew
Li, Jiong
Zhang, Yan
MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (02) : 429 - 439
[30] Network analysis of protein-protein interaction
Chang Shan
Gong XinQi
Jiao Xiong
Li ChunHua
Chen WeiZu
Wang CunXin
CHINESE SCIENCE BULLETIN, 2010, 55 (09): : 814 - 822

← 1 2 3 4 5 →